In order to analyze the associations between CK18 (both forms M30 and M65) with CVD risk in individuals from the PREVEND general population with NAFLD, we dichotomized PREVEND participants according to FLI values < or ≥60 [7,32]. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.